Sandostatin Lar 20 mg powder and solvent for suspension for injection
Valsts: Bulgārija
Valoda: bulgāru
Klimata pārmaiņas: Изпълнителна агенция по лекарствата
Lietošanas instrukcija
(PIL)
15-01-2024
Produkta apraksts
(SPC)
30-01-2023
Aktīvā sastāvdaļa:
Октреотид
Pieejams no:
Novartis Pharma GmbH
ATĶ kods:
H01CB2
SNN (starptautisko nepatentēto nosaukumu):
Octreotide
Deva:
20 mg powder and solvent for suspension for injection
Produktu pārskats:
Sandostatin LAR, 20 mg powder and solvent for suspension for injection
Autorizācija datums:
2015-03-11
